Arkolith/Insider Trading/KRTX/Form 4

Meury William

President and CEO, DirectorKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 18, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)19K$330.00$6.3M0
Mar 18, 2024Disposed to issuer(D)10K$330.00$3.4M19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 18, 2024Disposed to issuer(D)39K$330.00$12.8M0
Mar 18, 2024Disposed to issuer(D)63K$136.81$8.6M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-013928) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML